KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Long-Term Deferred Tax (2017 - 2025)

Novartis Ag's Long-Term Deferred Tax history spans 9 years, with the latest figure at $5.4 billion for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 24.75% year-over-year to $5.4 billion; the TTM value through Dec 2025 reached $5.4 billion, up 24.75%, while the annual FY2025 figure was $5.4 billion, 24.75% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $5.4 billion at Novartis Ag, up from $4.4 billion in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $5.4 billion in Q4 2025 and bottomed at $3.7 billion in Q4 2022.
  • The 5-year median for Long-Term Deferred Tax is $4.3 billion (2023), against an average of $4.3 billion.
  • The largest annual shift saw Long-Term Deferred Tax fell 4.83% in 2021 before it rose 24.75% in 2025.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $3.7 billion in 2021, then fell by 0.11% to $3.7 billion in 2022, then rose by 15.24% to $4.3 billion in 2023, then grew by 1.16% to $4.4 billion in 2024, then grew by 24.75% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Long-Term Deferred Tax are $5.4 billion (Q4 2025), $4.4 billion (Q4 2024), and $4.3 billion (Q4 2023).